Ribociclib Approved in England for Early-Stage Breast Cancer Treatment
Ribociclib is approved for early-stage breast cancer in England, reducing the risk of recurrence by 29%.
- September 5, 2025 4:32 pm
Ribociclib is approved for early-stage breast cancer in England, reducing the risk of recurrence by 29%.